News Headline Summary
AstraZeneca (AZN LN) says no boost from baseline in mean daily Opioid dose
- Co. announces results from long-term safety trial of Naloxegol in patients with Opioid induced constipation.
Reaction details (12:34)
- Co. shares unreactive, trades down 0.97% at GBP 29.49 last.
26 Feb 2013 - 12:31
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
Real-time audio coverage from 0630 to 2130 London time
Teams of analysts covering equities, fixed income, FX and energy markets
Real-time scrolling news service
Daily and weekly pre-market research and calendars
Intra-day market update videos
Daily technical analysis